Traditional Chinese medicinal decoction piece processing atomizing moistening and softening technology
A technology for Chinese medicinal materials and decoction pieces, which is applied in the field of spraying, moisturizing and softening technology for processing Chinese medicinal materials and decoction pieces, can solve the problems of low loss of effective components of medicinal materials, and achieve the effect of overcoming serious defects and ensuring retention.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] Taking Chonglou as an example, set the wetting temperature at 40°C, the humidity of the wetting medicine at 70%, and the wetting time of 25 minutes. Saponin VII, the pharmacopoeia stipulates that the content should not be less than 0.60%, and the content in the original medicinal material is about 0.658%, but only about 0.601% after the traditional process, which barely meets the pharmacopoeia regulations, and the active ingredients are seriously lost during the treatment process. The active ingredient content after the process treatment can reach about 0.651%, which is several times higher than that of the traditional process.
Embodiment 2
[0014] Take Astragalus membranaceus as an example, set the moistening temperature at 35°C, the moistening humidity at 80%, and the moistening time at 15 minutes. The active ingredients include astragaloside IV and calycosin glucoside, and the pharmacopoeia stipulates that the content of astragaloside IV should not be less than 0.040%, and the content of acteosin glucoside shall not be less than 0.020%. The content of astragaloside IV in the original medicinal material is about 0.049%, and the content of acteocoside glucoside is about 0.042%. The flavonoid glucoside is only about 0.034%, which barely meets the requirements of the Pharmacopoeia, and the active ingredients are seriously lost in the process of processing, while the content of astragaloside IV after the process of the present invention can reach about 0.046%, and the content of acteosin glucoside can reach 0.040% It is also several times higher than that of traditional crafts.
Embodiment 3
[0016] Take licorice as an example, set the moistening temperature at 44°C, the moistening humidity at 79%, and the moistening time at 35 minutes. The active ingredients include liquiritin and glycyrrhizic acid. The content of acid should not be less than 2.0%. The content of liquiritin and glycyrrhizic acid in the original medicinal materials is about 0.95%, and the content of glycyrrhizic acid is about 2.201%. However, after the traditional process, the content of liquiritin and glycyrrhizic acid is only about 0.85%, and the content of glycyrrhizic acid is only about 2.134%, barely reaching the pharmacopoeia regulations. , the active ingredient is seriously lost in the process of treatment, and the content of liquiritin after the process of the present invention can reach about 0.92%, and the content of glycyrrhizic acid can reach about 2.175%, which is still several times higher than that of the traditional process.
[0017] Through the above examples, it can be seen that th...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More